Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Lakefront Biotherapeutics NV (LKFT) vs. Competitors

4 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
NL:LKFTLakefront Biotherapeutics NVEUR 30.18EUR 1.99B4.0811.53%Moderate SellUnlock the NL:LKFT analyst price target with TipRanks PremiumNL:LKFTUnlock the NL:LKFT top-analyst price target with TipRanks Premium
NL:PHARMPharming GroupEUR 1.14EUR 807.58M35.72-23.37%―Unlock the NL:PHARM analyst price target with TipRanks PremiumNL:LKFT vs NL:PHARMUnlock the NL:PHARM top-analyst price target with TipRanks Premium
NL:VVYVivoryon Therapeutics AGEUR 0.77EUR 22.74M-3.34-53.17%―Unlock the NL:VVY analyst price target with TipRanks PremiumNL:LKFT vs NL:VVYUnlock the NL:VVY top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
NL:LKFTLakefront Biotherapeutics NV30.183.5613.37%
NL:PHARMPharming Group1.14-0.25-18.03%
NL:VVYVivoryon Therapeutics AG0.77-0.87-53.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts